Compare NRIM & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NRIM | SOPH |
|---|---|---|
| Founded | 1990 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 602.6M | 462.3M |
| IPO Year | 2002 | 2021 |
| Metric | NRIM | SOPH |
|---|---|---|
| Price | $27.25 | $7.50 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.50 |
| AVG Volume (30 Days) | 144.0K | ★ 422.9K |
| Earning Date | 04-22-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.62% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.29 | N/A |
| Revenue | ★ $255,581,000.00 | N/A |
| Revenue This Year | $4.98 | $23.09 |
| Revenue Next Year | $7.40 | $19.57 |
| P/E Ratio | $20.95 | ★ N/A |
| Revenue Growth | ★ 30.43 | N/A |
| 52 Week Low | $19.60 | $3.10 |
| 52 Week High | $95.61 | $7.88 |
| Indicator | NRIM | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 53.84 | 66.10 |
| Support Level | $25.99 | $4.63 |
| Resistance Level | $28.08 | N/A |
| Average True Range (ATR) | 0.51 | 0.48 |
| MACD | -0.02 | 0.13 |
| Stochastic Oscillator | 60.33 | 82.43 |
Northrim BanCorp Inc is a bank holding company operating through three reportable segments: Community Banking, Home Mortgage Lending, and Specialty Finance. The Community Banking segment, which generates the majority of revenue, provides loan and deposit products to business and consumer customers in its market areas. The Home Mortgage Lending segment focuses on the origination and sale of mortgage loans for one-to-four family residential properties, mortgage loan servicing for certain loans sold, and investment in selected residential mortgage loans. The Specialty Finance segment provides factoring, asset-based lending, and alternative working capital solutions to small and medium-sized enterprises and includes SCF and Northrim Funding Services.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.